Literature DB >> 12170459

Processing of sentinel lymph nodes for detection of metastatic melanoma.

Victor G Prieto1, Sandra H Clark.   

Abstract

Within the last years, evaluation of sentinel lymph nodes (SLN) has become the most popular method of early staging of several malignancies, including breast carcinoma and melanoma. Because SLN are reportedly the lymph nodes most likely to contain metastatic deposits, identification of such nodes allows pathologists to examine the tissue in a much more intense manner than with the usual lymphadenectomy specimens containing multiple lymph nodes. However, there is not a universally accepted standard protocol for pathologic processing of the SLN. Initially, the most popular protocols called for bisection of the SLN and examination of serial sections, with or without routinely performed immunohistochemistry. Lately, other protocols have been proposed to try to simplify the histologic analysis while providing at least equivalent results. Here we review the different protocols used for the evaluation of SLN and describe the protocol currently in use at M. D. Anderson Cancer Center (Houston, TX). Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12170459     DOI: 10.1053/adpa.2002.35400

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  8 in total

1.  Evaluation of a radioactive and fluorescent hybrid tracer for sentinel lymph node biopsy in head and neck malignancies: prospective randomized clinical trial to compare ICG-(99m)Tc-nanocolloid hybrid tracer versus (99m)Tc-nanocolloid.

Authors:  Ingo Stoffels; Julia Leyh; Thorsten Pöppel; Dirk Schadendorf; Joachim Klode
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-05-31       Impact factor: 9.236

2.  Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma.

Authors:  Jeffrey E Gershenwald; Robert H I Andtbacka; Victor G Prieto; Marcella M Johnson; A Hafeez Diwan; Jeffrey E Lee; Paul F Mansfield; Janice N Cormier; Christopher W Schacherer; Merrick I Ross
Journal:  J Clin Oncol       Date:  2008-07-07       Impact factor: 44.544

3.  Features of sentinel lymph nodes for melanoma may lead to re-diagnosis of the cutaneous primary: an unusual case and review of literature.

Authors:  Rathi Ramakrishnan; Richard Young; Barry Powell; M G Cook
Journal:  Virchows Arch       Date:  2004-09-09       Impact factor: 4.064

4.  Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

Authors:  Jeffrey E Gershenwald; Richard A Scolyer; Kenneth R Hess; Vernon K Sondak; Georgina V Long; Merrick I Ross; Alexander J Lazar; Mark B Faries; John M Kirkwood; Grant A McArthur; Lauren E Haydu; Alexander M M Eggermont; Keith T Flaherty; Charles M Balch; John F Thompson
Journal:  CA Cancer J Clin       Date:  2017-10-13       Impact factor: 508.702

5.  Sentinel lymph node biopsy for conjunctival malignant melanoma: surgical techniques.

Authors:  Alberto Ja Wainstein; Ana P Drummond-Lage; Milhem Jm Kansaon; Gustavo O Bretas; Rodrigo F Almeida; Ana Lf Gloria; Ana Rp Figueiredo
Journal:  Clin Ophthalmol       Date:  2014-12-16

Review 6.  The Role and Necessity of Sentinel Lymph Node Biopsy for Invasive Melanoma.

Authors:  Yasuhiro Nakamura
Journal:  Front Med (Lausanne)       Date:  2019-10-22

7.  Quantitative measurement of melanoma spread in sentinel lymph nodes and survival.

Authors:  Anja Ulmer; Klaus Dietz; Isabelle Hodak; Bernhard Polzer; Sebastian Scheitler; Murat Yildiz; Zbigniew Czyz; Petra Lehnert; Tanja Fehm; Christian Hafner; Stefan Schanz; Martin Röcken; Claus Garbe; Helmut Breuninger; Gerhard Fierlbeck; Christoph A Klein
Journal:  PLoS Med       Date:  2014-02-18       Impact factor: 11.069

8.  Impact of the 2009 (7th edition) AJCC melanoma staging system in the classification of thin cutaneous melanomas.

Authors:  Vicki H Chu; Michael T Tetzlaff; Carlos A Torres-Cabala; Victor G Prieto; Roland Bassett; Jeffrey E Gershenwald; Michael S McLemore; Doina Ivan; Wei-Lien Billy Wang; Merrick I Ross; Jonathan L Curry
Journal:  Biomed Res Int       Date:  2013-12-03       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.